84-5465-71 [取扱停止]FAM80A 30ul 536230
特徴
- RIMKLA (N-acetylaspartyl-glutamate synthetase A) is a 391aa protein that belongs to the rimK family.
- Localizing to cytoplasm, RIMKLA contains one ATP-grasp domain and binds two manganese ions per subunit.
- RIMKLA catalyzes the synthesis of N-acetylaspartyl-glutamate (NAAG).
- RIMKLA, is almost exclusively expressed in the CNS, whereas RIMKLB, which shares 65% sequence identity with RIMKLA, is expressed in CNS and testis.
- It has also been suggested that RIMKLA and RIMKLB also served to ligate free glutamate to (an) acceptor (s).
- RIMKLA catalyzed the ATP-dependent synthesis of N-acetylaspartylglutamate (NAAG) from N-acetylaspartate and L-glutamate.
- RIMKLB catalyzed this reaction as well as the synthesis of beta-citrylglutamate.
- The RIMKLA gene is conserved in chimpanzee, canine, cow and mouse, and maps to human chromosome 1p34.2.
- Applications:Suitable for use in Western Blot and ELISA.
- Other applications not tested.
- Recommended Dilution:Western Blot: 1:500-1:2000ELISA: 1:20,000Optimal dilutions to be determined by the researcher.
- Storage and Stability:May be stored at 4°C for short-term only.
- Aliquot to avoid repeated freezing and thawing.
- Store at -20°C.
- Aliquots are stable for 12 months after receipt.
- For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
仕様
- Size:30ul
- Host:rabbit
- Source Antibody:human
- Grade:Affinity Purified
- Purity:Purified by immunoaffinity chromatography.
- Form:Supplied as a liquid in PBS, 0.5% BSA, 0.02% sodium azide, 50% glycerol.
- Specificity:Recognizes endogenous levels of human FAM80A. Species Crossreactivity: mouse, monkey
- Isotype:IgG
- Calc Applications Abbrev:E WB
- Calc Crossreactivity:Hu Mk Mo
- Immunogen:Synthetic peptide corresponding to aa90-170 of human FAM80A.
- Swiss Prot Number:Q8IXN7
- この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
- 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL:06-6447-8641
- FAX:06-6447-8642
- E-mail:[email protected]